TRIAD3A AS A MOLECULAR TARGET TO ENHANCE THE EFFICACY OF CPG-ODN FOR BREAST CANCER THERAPY

$186,400FY2008Department of the ArmyDOD

Sidney Kimmel Cancer Center, San Diego CA

Investigators

TRIAD3A AS A MOLECULAR TARGET TO ENHANCE THE EFFICACY OF CPG-ODN FOR BREAST CANCER THERAPY · GrantIndex